Abercrombie & Fitch Company (ANF) 16.94 $ANF Post

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Abercrombie & Fitch Company (ANF) 16.94 $ANF

Post Earnings Coverage as Abercrombie Financial Results Hit by Declining Sales
ACCESSWIRE - Thu Sep 01, 8:15AM CDT
LONDON, UK / ACCESSWIRE / September 1, 2016 / Active Wall St. announces its post-earnings coverage on Abercrombie & Fitch Co. (NYSE: ANF). The company reported second quarter fiscal 2016 results on August 30th, 2016. The teen apparel retailer reported a bigger-than-expected loss, hurt by declining sales at its larger flagship locations. Register with us now for your free membership at: http://www.activewallst.com/register/.
ANF: 16.94 (-0.08), GIII: 31.90 (-0.98)

Downgrade Alert for Abercrombie & Fitch (ANF)
Comtex SmarTrend(R) - Thu Sep 01, 3:27AM CDT
Abercrombie & Fitch (NYSE:ANF) was downgraded from Buy to Hold at Stifel today. The stock closed yesterday at $17.74 on volume of 7.2 million shares, above average daily volume of 1.6 million. Abercrombie & Fitch (NYSE:ANF) has potential upside of 32.7% based on a current price of $17.74 and analysts' consensus price target of $23.54. Abercrombie & Fitch shares should first meet resistance at the 200-day moving average (MA) of $24.54 and find additional resistance at the 50-day MA of $29.84.
ANF: 16.94 (-0.08)

Shopping Mall Resurgence: 3 Retails Stocks to Buy Now
Ryan McQueeney - Zacks Investment Research - Wed Aug 31, 1:56PM CDT
After years of evolving trends and shoppers moving online, the once-iconic American shopping mall no longer seemed relevant. Nevertheless, the success of some retail stocks this earnings season shows us that mall-based retailers are making a comeback.
URBN: 35.19 (-0.91), ANF: 16.94 (-0.08), AEO: 18.40 (unch), FL: 65.99 (-0.01)

Company News for August 31, 2016
Zacks Equity Research - Zacks Investment Research - Wed Aug 31, 9:10AM CDT
Companies in the News are: AAPL,HSY,MDLZ,ANF,HRB
MDLZ: 44.42 (+0.23), HSY: 99.79 (+0.49), ANF: 16.94 (-0.08), AAPL: 107.70 (-0.03), HRB: 21.39 (-0.26)

A Closer Look at Abercrombie and Fitch Post Earnings
ACCESSWIRE - Wed Aug 31, 8:16AM CDT
NEW YORK, NY / ACCESSWIRE / August 31, 2016 / Abercrombie & Fitch Co. (NYSE: ANF) shares fell 20.29 percent to close at $18.29 a share Tuesday. The stock traded between $18.06 and $19.51 on volume of 23.02 million shares traded. The stock appears to be facing some resistance at $18.45 and $19.42 with some support at $16.80. On Tuesday, the retailer reported earnings for the second quarter that fell short of expectations. Abercrombie's sales dropped for the 14th straight quarter and comparable sales fell a slightly steeper-than-expected, mainly due to lower traffic, including from tourists, at its flagship stores. The company no longer expects comparable sales to improve this year.
ANF: 16.94 (-0.08)

Upgrade Alert for Abercrombie & Fitch (ANF)
Comtex SmarTrend(R) - Wed Aug 31, 3:15AM CDT
Abercrombie & Fitch (NYSE:ANF) was upgraded from Hold to Buy at Standpoint Research today. The stock closed yesterday at $18.29 on volume of 22.6 million shares, above average daily volume of 1.6 million. Abercrombie & Fitch Co. is a specialty retailer that operates stores selling casual apparel, such as knit shirts, graphic t-shirts, jeans, woven shirts and personal care and other accessories for men, women and kids. The Company operates stores in the United States and Canada as well as retails its products over the Internet.
ANF: 16.94 (-0.08)

Abercrombie (ANF) An Outlier Among Strong Shopping Mall Stocks
Ryan McQueeney - Zacks Investment Research - Tue Aug 30, 4:51PM CDT
Shares of Abercrombie & Fitch (ANF) fell over 20% on Tuesday after the specialty retailer reported lackluster second-quarter financial results. Interestingly enough, Abercrombie's performance is in direct contrast to some of its biggest competitors throughout the shopping mall retail landscape, which has seen a resurgence this earnings season.
TLYS: 9.46 (+0.39), URBN: 35.19 (-0.91), ANF: 16.94 (-0.08), AEO: 18.40 (unch), FL: 65.99 (-0.01)

Business Highlights
By The Associated Press - AP - Tue Aug 30, 4:14PM CDT
___
ANF: 16.94 (-0.08), CMG: 414.07 (+5.66)

Hershey, Abercrombie & Fitch sink; United Continental gains
AP - Tue Aug 30, 3:56PM CDT
NEW YORK (AP) — Stocks that moved substantially or traded heavily on Tuesday:
AGU.TO: 123.72 (-3.91), MDLZ: 44.42 (+0.23), CBK: 1.39 (-0.06), ANF: 16.94 (-0.08), AGU: 96.35 (-1.83), AAPL: 107.70 (-0.03), UAL: 51.14 (+0.05)

2 Stocks to Watch Before the Market Opens Tomorrow
ESTMZ - Tue Aug 30, 3:00PM CDT
Bob Evans Restaurants ( BOBE ): The restaurant chain has fallen victim to changing consumer dining preferences. While earnings have beaten expectations in recent quarters, revenue has been sideways for almost 2 years now. The stock has been just as...
SPY: 219.03 (+0.66), ANF: 16.94 (-0.08), BOBE: 39.53 (-0.48), GPS: 23.43 (-0.49), CHS: 12.57 (-0.06)

Abercrombie (ANF) Stock Down on Wider Loss & Soft Sales
Zacks Equity Research - Zacks Investment Research - Tue Aug 30, 9:16AM CDT
Abercrombie & Fitch Co.'s (ANF) shares plunged over 13% in the pre-market trading session after the company reported dismal second-quarter fiscal 2016 results.
LB: 73.33 (-0.86), PLCE: 83.09 (+0.09), ANF: 16.94 (-0.08), AEO: 18.40 (unch)

Abercrombie (ANF) Posts Wider-than-Expected Q2 Loss
Sumit Singh - Zacks Investment Research - Tue Aug 30, 8:08AM CDT
Abercrombie & Fitch (ANF) reported adjusted loss of 25 cents per share, wider than the Zacks Consensus Estimate of loss of 23 cents.
ANF: 16.94 (-0.08)

ABERCROMBIE & FITCH REPORTS SECOND QUARTER RESULTS
Globe Newswire - Tue Aug 30, 6:30AM CDT
New Albany, Ohio, August 30, 2016: Abercrombie & Fitch Co. (NYSE: ANF) today reported a GAAP net loss per diluted share of $0.19 for the second quarter ended July 30, 2016, compared to a GAAP net loss per diluted share of $0.01 for the second quarter last year. Excluding certain items, the company reported an adjusted non-GAAP net loss per diluted share of $0.25 for the second quarter, compared to adjusted non-GAAP net income per diluted share of $0.12 last year. The results for the quarter reflect an adverse impact related to year-over-year changes in foreign currency exchange rates of approximately $0.08 per diluted share.
ANF: 16.94 (-0.08)

Watch for Abercrombie & Fitch to Potentially Pullback After Gaining 1.79% Yesterday
Comtex SmarTrend(R) - Mon Aug 29, 1:46PM CDT
Abercrombie & Fitch (NYSE:ANF) traded in a range yesterday that spanned from a low of $22.54 to a high of $23.29. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $23.29 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ANF: 16.94 (-0.08)

Abercrombie & Fitch Rises 1.79% on Heavy Volume: Watch For Potential Pullback
Comtex SmarTrend(R) - Mon Aug 29, 1:45PM CDT
Abercrombie & Fitch (NYSE:ANF) traded in a range yesterday that spanned from a low of $22.54 to a high of $23.29. Yesterday, the shares gained 1.8%, which took the trading range above the 3-day high of $23.29 on volume of 1.8 million shares. Often times after large one-day gains, short term traders will seek to take profits and, as such, investors should be cautious.
ANF: 16.94 (-0.08)

5 Stocks to Watch this Week 8/29 - CRM, PANW, ANF, AMBA, SWHC
ESTMZ - Mon Aug 29, 8:00AM CDT
Monday, August 29 Tuesday, August 30 Thursday, September 1 Salesforce ( CRM ) Information Technology - Software | Reports August 29, after the close. The Estimize consensus is looking for earnings of $0.24 per share on...
AMBA: 68.88 (+1.89), SPY: 219.03 (+0.66), ANF: 16.94 (-0.08), PANW: 144.97 (-0.21), SWHC: 27.96 (+0.27), CRM: 75.42 (+0.32)

High School and College Students Promote Social Change
PRWeb - Fri Aug 26, 1:32PM CDT
Abercrombie & Fitch Co. (NYSE: ANF) and the National Society of High School Scholars (NSHSS) are excited to announce the winners of the 2016 A&F Diversity Champion Awards. Ten $2,500 scholarships have been awarded to students who demonstrate leadership and diversity in their schools and communities.
ANF: 16.94 (-0.08)

ANF October 7th Options Begin Trading
DividendChannel.com - Thu Aug 25, 9:38AM CDT
Investors in Abercrombie & Fitch Co. saw new options become available today, for the October 7th expiration.
ANF: 16.94 (-0.08)

Abercrombie & Fitch Set to Possibly Rebound After Yesterday's Selloff of 1.67%
Comtex SmarTrend(R) - Wed Aug 24, 2:45PM CDT
Abercrombie & Fitch (NYSE:ANF) traded in a range yesterday that spanned from a low of $21.91 to a high of $22.40. Yesterday, the shares fell 1.7%, which took the trading range below the 3-day low of $22.05 on volume of 933,000 shares. Often times after large one-day declines, short-term traders may play for some degree of mean reversion.
ANF: 16.94 (-0.08)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Delhi Pushes Innovation Against Dryland Challenges

Updated Category News Views 4

Evolution of South-South Agricultural Cooperation Let's just say if there's a time to shine a spotlight on the arid lands of our world, it's now. The Global Drylands Congress 2026 in New Delhi put a sharp focus on scaling agricultural innovation across these thirsty regions. With climate change breathing down our necks, talking shop about food security isn't just for show...

Continue Reading
PathoSearch: A New Era in Pathology With Visual Search

Updated Category News Views 7

Revolutionizing Pathology with a Visual Search Engine In an era where time is money and precision is paramount, Aignostics is betting big on transforming the pathology landscape. Today, their announcement of PathoSearch, a visual search engine designed for retrieving comparable diagnosed pathology cases, marks a massive leap towards streamlining the diagnostic process....

Continue Reading
Nocpix Unveils ACE 2 Thermal Riflescope Lineup

Updated Category News Views 3

ACE 2: A Thermal Riflescope That Promises More Let’s dive right into the nitty-gritty of Nocpix’s latest move. On September 12, they launched the ACE 2 Series—the next-gen beast of their flagship thermal riflescope lineup. A step up from the original ACE, this series aims to redefine what hunters can expect from a riflescope, introducing three models: ACE 2 S60R,...

Continue Reading
ARTiSTORY's Strategic Advance in Cultural IP Licensing

Updated Category News Views 5

Call it a seismic shift or call it common sense, but ARTiSTORY's recent haul of accolades makes it clear: they're onto something big in the cultural IP game. Receiving four honors at the 26th International Advertising Institute Awards (IAI Awards), including a Gold for their British Library × CHAGEE collaboration, and jumping into License Global's Top 60, they're staking...

Continue Reading
SystImmune's Data on Iza-bren Show Promise for Lung Cancer

Updated Category News Views 7

Stepping into New Territory with SystImmune Amid the cacophony of biotech whispers and the marketplace hum, SystImmune is trotting out something that might just make the folks in lab coats raise an eyebrow. They’ve got new data for Iza-bren—none of that flashy PR chatter—but it's damn promising if you ask me. At the World Conference on Lung Cancer in Seoul,...

Continue Reading
Silk Road Maritime Extends Its Global Reach in 2026

Updated Category News Views 4

China-Europe Trade Ties Continue to Tighten You ever watch a cargo ship glide into port and think, "There's a piece of the future right there”? Well, that's the scene at Poland’s Gdansk Port, now officially etched into the Silk Road Maritime route. This ain't just a couple of extra boats cutting through choppy waters—it's a great leap forward for a strained global...

Continue Reading
Countries Eye New Investment Paths at CIFIT 2026

Updated Category News Views 3

Global Investment Winds Shift at CIFIT In the thick of a world that's being turned on its head, you've got big shots from 129 countries and 30 international organizations talking shop at the 26th China International Fair for Investment and Trade (CIFIT) in Xiamen. Take your pick from the 48 of the world's top 50 GDP powerhouses rubbing shoulders there—this ain't your...

Continue Reading
IASLC Boosts Global Thoracic Cancer Collaboration

Updated Category News Views 3

Breaking Down Barriers in Thoracic Oncology Picture a world where financial walls don't block innovation and knowledge sharing in cancer treatment. The International Association for the Study of Lung Cancer (IASLC) is leading the charge here. They've just launched a new initiative offering complimentary full membership to qualified healthcare professionals in low- and...

Continue Reading

Top 5 Most Recently Viewed Articles

Revolutionary Device Transforms Golf Ball Pickup Experience

Updated Category News Views 451

Revolutionary Device Enhances Golf Ball Retrieval Inventors are always looking for ways to simplify tasks and improve our experiences. One innovative creator has unveiled a practical solution for golfers: the BALL PICK. This device addresses a common struggle faced by golfers at all skill levels – the hassle of bending down to pick up golf balls. Imagine a device that...

Continue Reading
HCSC Introduces Simplified Health Care Coverage Alternative

Updated Category News Views 321

HCSC Launches a New Streamlined Health Care Coverage Option Health Care Service Corporation (HCSC) is thrilled to announce a new health plan designed to simplify the healthcare experience for its members. This innovative option is aimed at individuals looking for a more straightforward way to handle their healthcare expenses. Simplified Monthly Billing with No Deductibles...

Continue Reading
Desvelados Mexican Cantina: A Flavorful New Gem in Town

Updated Category News Views 314

Desvelados Mexican Cantina Is Now Open In a vibrant celebration, Desvelados Mexican Cantina has opened its doors, bringing authentic Mexican flavors to the local dining scene. This lively cantina invites food lovers to indulge in an array of mouthwatering dishes, making it the perfect spot for gatherings with friends and family. Dining Experience at Desvelados Upon...

Continue Reading
Promising Results from Arcus Biosciences’ Casdatifan in Cancer Trials

Updated Category News Views 67

Groundbreaking Developments in Cancer Treatment Arcus Biosciences, Inc. (NYSE:RCUS), a leader in biopharmaceutical innovation, has recently presented compelling clinical data regarding their leading candidate, casdatifan, a HIF-2a inhibitor that shows outstanding promise in treating metastatic kidney cancer. The data was shared by Dr. Toni K. Choueiri at a significant...

Continue Reading
Understanding Options Movement in Johnson & Johnson Stock

Updated Category News Views 203

Key Insights on Johnson & Johnson Options Activity Investors are paying close attention to the options market for Johnson & Johnson (NYSE: JNJ), as recent activities indicate a bearish stance among high-profile investors. Understanding these movements can be valuable for retail traders looking to navigate the complexities of stock trading. Recent Options Trends Recently,...

Continue Reading